GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Shiller PE Ratio

Pharma Mar (XMAD:PHM) Shiller PE Ratio : 26.68 (As of May. 26, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Shiller PE Ratio?

As of today (2024-05-26), Pharma Mar's current share price is €36.02. Pharma Mar's E10 for the quarter that ended in Mar. 2024 was €1.35. Pharma Mar's Shiller PE Ratio for today is 26.68.

The historical rank and industry rank for Pharma Mar's Shiller PE Ratio or its related term are showing as below:

XMAD:PHM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.44   Med: 51.5   Max: 541.41
Current: 26.74

During the past years, Pharma Mar's highest Shiller PE Ratio was 541.41. The lowest was 19.44. And the median was 51.50.

XMAD:PHM's Shiller PE Ratio is ranked better than
61.44% of 153 companies
in the Biotechnology industry
Industry Median: 34.13 vs XMAD:PHM: 26.74

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pharma Mar's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.131. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €1.35 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pharma Mar Shiller PE Ratio Historical Data

The historical data trend for Pharma Mar's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Shiller PE Ratio Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 124.65 50.12 44.24 28.73

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.15 21.33 22.14 28.73 21.33

Competitive Comparison of Pharma Mar's Shiller PE Ratio

For the Biotechnology subindustry, Pharma Mar's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Shiller PE Ratio falls into.



Pharma Mar Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pharma Mar's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=36.02/1.35
=26.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Pharma Mar's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.131/122.7621*122.7621
=0.131

Current CPI (Mar. 2024) = 122.7621.

Pharma Mar Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.008 101.081 -0.010
201409 0.042 100.441 0.051
201412 -0.241 100.251 -0.295
201503 0.358 99.474 0.442
201506 -0.176 101.138 -0.214
201509 0.239 99.559 0.295
201512 -0.060 100.268 -0.073
201603 -0.387 98.638 -0.482
201606 -0.328 100.333 -0.401
201609 -0.185 99.737 -0.228
201612 -0.407 101.842 -0.491
201703 -0.134 100.896 -0.163
201706 -0.271 101.848 -0.327
201709 -0.381 101.524 -0.461
201712 -0.666 102.975 -0.794
201803 -0.071 102.122 -0.085
201806 0.237 104.165 0.279
201809 -0.226 103.818 -0.267
201812 -0.240 104.193 -0.283
201903 -0.568 103.488 -0.674
201906 -0.588 104.612 -0.690
201909 -0.306 103.905 -0.362
201912 0.843 105.015 0.985
202003 3.815 103.469 4.526
202006 2.353 104.254 2.771
202009 0.952 103.521 1.129
202012 0.341 104.456 0.401
202103 1.332 104.857 1.559
202106 1.048 107.102 1.201
202109 0.633 107.669 0.722
202112 2.119 111.298 2.337
202203 1.220 115.153 1.301
202206 0.716 118.044 0.745
202209 0.467 117.221 0.489
202212 0.331 117.650 0.345
202303 0.079 118.948 0.082
202306 0.279 120.278 0.285
202309 0.085 121.343 0.086
202312 -0.387 121.300 -0.392
202403 0.131 122.762 0.131

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pharma Mar  (XMAD:PHM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pharma Mar Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (XMAD:PHM) Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.